Participants

HH Hao Hu
HL Haiyan Li
JL Jieqiong Li
JY Jintai Yu
LT Lan Tan
ask Ask a question
Favorite

Our ADNI cohort included all healthy controls (HC), MCI group and AD group participants with available baseline CSF BACE samples and genotype data. To reduce the likelihood of population stratification effects in the GWAS, all the participants were restricted to non-Hispanic Caucasians. We also tested a multidimensional scaling (MDS) plot and found some genetic outliers (Additional file 1). After quality control (QC) of the CSF BACE data and removal of the outliers, there were 340 participants (AD = 86, MCI = 163, HC = 91) with CSF BACE data left. Detailed QC steps for CSF and genotype data have been previously reported and are briefly described below.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A